BioSpace

Hims & Hers’ Woes Compound as FDA Hits Company With Warning Letter

The agency flagged several violations at a compounding pharmacy owned by Hims & Hers, including “infestation by rodents, ...
STAT

FDA warned a Hims & Hers compounder after finding bugs and failing to report a serious side effect

FDA inspectors found a live spider and dead cricket in a facility that was compounding weight loss drugs for Hims & Hers.

Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds

Hims & Hers stock fell sharply on Monday after the FDA said it would take steps to restrict the sale of its compounded ...

US signals crackdown on compounded weight-loss drugs; Hims shares tumble

By Leah Douglas and Siddhi Mahatole Feb 6 (Reuters) - The U.S. Food and Drug Administration said on Friday it would take ...
Fierce Pharma

UPDATE: FDA's Makary pledges crackdown on mass marketing of 'illegal copycat drugs' in wake of Hims' Wegovy pill push

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...
PharmExec

Hims & Hers Pulls Access to Compounded Semaglutide Pill Following Controversial Launch

Novo Nordisk, the manufacturer of Wegovy, responded strongly to the initial launch of Hims & Hers’ compounded semaglutide ...
The Pharma Letter

Novo Nordisk to sue Hims & Hers over illegal compounding

Danish drugmaker's Novo Nordisk’s shares fell more than 8% on Thursday after Hims & Hers announced that it would be releasing ...
Healthcare Dive

Hims cancels plans to sell compounded GLP-1 pill after FDA backlash

Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s ...

US could take action including fines against Hims after brief Wegovy copy launch

The Trump administration could take action including an injunction or fines against online telehealth company Hims for intending to sell a compounded version of Novo Nordisk's Wegovy weight-loss pill, ...